Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001564590-20-024840
Filing Date
2020-05-13
Accepted
2020-05-13 06:15:35
Documents
7
Period of Report
2020-06-16
Effectiveness Date
2020-05-13

Document Format Files

Seq Description Document Type Size
1 DEF 14A pstv-def14a_20200616.htm DEF 14A 967874
2 GRAPHIC ghrbttaf31if000001.jpg GRAPHIC 49190
3 GRAPHIC ghrbttaf31if000007.jpg GRAPHIC 83732
4 GRAPHIC ghrbttaf31if000006.jpg GRAPHIC 3731
5 GRAPHIC ghrbttaf31if000008.jpg GRAPHIC 55587
6 GRAPHIC ghrbttaf31if000002.jpg GRAPHIC 3731
7 GRAPHIC ghrbttaf31if000004.jpg GRAPHIC 3731
  Complete submission text file 0001564590-20-024840.txt   1240813
Mailing Address 4200 MARATHON BLVD. SUITE 200 AUSTIN TX 78756
Business Address 4200 MARATHON BLVD. SUITE 200 AUSTIN TX 78756 737.255.7194
PLUS THERAPEUTICS, INC. (Filer) CIK: 0001095981 (see all company filings)

EIN.: 330827593 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-34375 | Film No.: 20870960
SIC: 3841 Surgical & Medical Instruments & Apparatus